English
Insider transactions
EDGARDBV Technologies S.A
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-22.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 5 transactions, 3,370,091 shares
- Sum of shares × price per share: 15,487,991.21
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–9 of 9
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-29 Filed 2026-07-31 | Mohideen Pharis Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 464 | 2.70 | 1,252.8Derived: shares × price per share. Exact value 1252.80. | 144,531 | Direct (D) | No | F1, F2, F3
| Open filing 0001760395-26-000008 Read from the filing’s XML Dispute this row |
| 2026-01-29 Filed 2026-02-02 | Mohideen Pharis Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 534 | 4.86 | 2,595.24Derived: shares × price per share. Exact value 2595.24. | 144,995 | Direct (D) | No | F1, F2, F3
| Open filing 0001760395-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-14 | BAKER BROS. ADVISORS LP DirectorBaker Bros. Advisors (GP) LLC Director667, L.P. DirectorBaker Brothers Life Sciences LP DirectorBAKER FELIX DirectorBAKER JULIAN Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 2,299,656 | 0 | — | 0 | Indirect (I) See Footnotes | No | F1, F2, F7, F8, F9, F3, F4, F5
| Open filing 0001193125-26-012991 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-14 | BAKER BROS. ADVISORS LP DirectorBaker Bros. Advisors (GP) LLC Director667, L.P. DirectorBaker Brothers Life Sciences LP DirectorBAKER FELIX DirectorBAKER JULIAN Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 25,005,240 | 0 | — | 0 | Indirect (I) See Footnotes | No | F1, F2, F7, F8, F9, F4, F5, F6
| Open filing 0001193125-26-012991 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-14 | BAKER BROS. ADVISORS LP DirectorBaker Bros. Advisors (GP) LLC Director667, L.P. DirectorBaker Brothers Life Sciences LP DirectorBAKER FELIX DirectorBAKER JULIAN Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 2,299,656 | 0 | — | 2,299,656 | Indirect (I) See Footnotes | No | F1, F7, F8, F9, F3, F4, F5
| Open filing 0001193125-26-012991 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-14 | BAKER BROS. ADVISORS LP DirectorBaker Bros. Advisors (GP) LLC Director667, L.P. DirectorBaker Brothers Life Sciences LP DirectorBAKER FELIX DirectorBAKER JULIAN Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 25,005,240 | 0 | — | 25,005,240 | Indirect (I) See Footnotes | No | F1, F7, F8, F9, F4, F5, F6
| Open filing 0001193125-26-012991 Read from the filing’s XML Dispute this row |
| 2025-12-18 Filed 2025-12-19 | EPIC Bpifrance Other: Member of 10% owner groupBpifrance Participations SA Other: Member of 10% owner groupBpifrance SA Other: Member of 10% owner groupBpifrance Investissement S.A.S. Other: Member of 10% owner groupCAISSE DES DEPOTS ET CONSIGNATIONS Other: Member of 10% owner group | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,292,103 | 4.19 | 5,413,911.57Derived: shares × price per share. Exact value 5413911.57. | 7,303,369 | Indirect (I) By Bpifrance Participations S.A. | No | F4, F2
| Open filing 0001104659-25-123104 Read from the filing’s XML Dispute this row |
| 2025-12-17 Filed 2025-12-19 | EPIC Bpifrance Other: Member of 10% owner groupBpifrance Participations SA Other: Member of 10% owner groupBpifrance SA Other: Member of 10% owner groupBpifrance Investissement S.A.S. Other: Member of 10% owner groupCAISSE DES DEPOTS ET CONSIGNATIONS Other: Member of 10% owner group | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,036,990 | 4.84 | 9,859,031.6Derived: shares × price per share. Exact value 9859031.60. | 8,635,472 | Indirect (I) By Bpifrance Participations S.A. | No | F1, F2
| Open filing 0001104659-25-123104 Read from the filing’s XML Dispute this row |
| 2025-12-17 Filed 2025-12-19 | EPIC Bpifrance Other: Member of 10% owner groupBpifrance Participations SA Other: Member of 10% owner groupBpifrance SA Other: Member of 10% owner groupBpifrance Investissement S.A.S. Other: Member of 10% owner groupCAISSE DES DEPOTS ET CONSIGNATIONS Other: Member of 10% owner group | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 40,000 | 5.28 | 211,200Derived: shares × price per share. Exact value 211200.00. | 8,595,472 | Indirect (I) By Bpifrance Participations S.A. | No | F3, F2
| Open filing 0001104659-25-123104 Read from the filing’s XML Dispute this row |
Latest reported holdings
What each reporting owner last said they hold, as of the date shown. A transaction not yet filed is not in it.
| Reporting owner | Security | Shares owned after | Direct or indirect | Source |
|---|---|---|---|---|
| 667, L.P. Director | BS Warrant Derivative security · underlying Second Pre-Funded Warrant | 0 | I See Footnotes | As of 2026-01-12 Open filing 4 |
| 667, L.P. Director · 10% owner | First Pre-Funded Warrant Derivative security · underlying Ordinary Shares | 25,005,240 | I See Footnotes | As of 2025-03-27 Open filing 4 |
| 667, L.P. Director | Second Pre-Funded Warrant Derivative security · underlying Ordinary Shares | 25,005,240 | I See Footnotes | As of 2026-01-12 Open filing 4 |
| BAKER BROS. ADVISORS LP Director | BS Warrant Derivative security · underlying Second Pre-Funded Warrant | 0 | I See Footnotes | As of 2026-01-12 Open filing 4 |
| BAKER BROS. ADVISORS LP Director · 10% owner | First Pre-Funded Warrant Derivative security · underlying Ordinary Shares | 25,005,240 | I See Footnotes | As of 2025-03-27 Open filing 4 |
| BAKER BROS. ADVISORS LP Director | Second Pre-Funded Warrant Derivative security · underlying Ordinary Shares | 25,005,240 | I See Footnotes | As of 2026-01-12 Open filing 4 |
| BAKER FELIX Director | BS Warrant Derivative security · underlying Second Pre-Funded Warrant | 0 | I See Footnotes | As of 2026-01-12 Open filing 4 |
| BAKER FELIX Director · 10% owner | First Pre-Funded Warrant Derivative security · underlying Ordinary Shares | 25,005,240 | I See Footnotes | As of 2025-03-27 Open filing 4 |
| BAKER FELIX Director | Second Pre-Funded Warrant Derivative security · underlying Ordinary Shares | 25,005,240 | I See Footnotes | As of 2026-01-12 Open filing 4 |
| BAKER JULIAN Director | BS Warrant Derivative security · underlying Second Pre-Funded Warrant | 0 | I See Footnotes | As of 2026-01-12 Open filing 4 |
| BAKER JULIAN Director · 10% owner | First Pre-Funded Warrant Derivative security · underlying Ordinary Shares | 25,005,240 | I See Footnotes | As of 2025-03-27 Open filing 4 |
| BAKER JULIAN Director | Second Pre-Funded Warrant Derivative security · underlying Ordinary Shares | 25,005,240 | I See Footnotes | As of 2026-01-12 Open filing 4 |
| Baker Bros. Advisors (GP) LLC Director | BS Warrant Derivative security · underlying Second Pre-Funded Warrant | 0 | I See Footnotes | As of 2026-01-12 Open filing 4 |
| Baker Bros. Advisors (GP) LLC Director · 10% owner | First Pre-Funded Warrant Derivative security · underlying Ordinary Shares | 25,005,240 | I See Footnotes | As of 2025-03-27 Open filing 4 |
| Baker Bros. Advisors (GP) LLC Director | Second Pre-Funded Warrant Derivative security · underlying Ordinary Shares | 25,005,240 | I See Footnotes | As of 2026-01-12 Open filing 4 |
| Baker Brothers Life Sciences LP Director | BS Warrant Derivative security · underlying Second Pre-Funded Warrant | 0 | I See Footnotes | As of 2026-01-12 Open filing 4 |
| Baker Brothers Life Sciences LP Director · 10% owner | First Pre-Funded Warrant Derivative security · underlying Ordinary Shares | 25,005,240 | I See Footnotes | As of 2025-03-27 Open filing 4 |
| Baker Brothers Life Sciences LP Director | Second Pre-Funded Warrant Derivative security · underlying Ordinary Shares | 25,005,240 | I See Footnotes | As of 2026-01-12 Open filing 4 |
| Boucinha Virginie Officer: Chief Financial Officer | Employee Stock Option (right to buy) Derivative security · underlying Ordinary Shares | 192,000 | D | As of 2025-11-21 Open filing 4 |
| Boucinha Virginie Officer: Chief Financial Officer | Ordinary Shares | 70,000 | D | As of 2025-11-21 Open filing 4 |
| Bpifrance Investissement S.A.S. Other: Member of 10% owner group | Ordinary Shares | 226,133 | I By Innobio FPCI | As of 2025-12-19 Open filing 4 |
| Bpifrance Investissement S.A.S. Other: Member of 10% owner group | Ordinary Shares | 7,303,369 | I By Bpifrance Participations S.A. | As of 2025-12-18 Open filing 4 |
| Bpifrance Participations SA 10% owner | Ordinary Shares | 10,672,462 | I By Bpifrance Participations S.A. | As of 2025-04-07 Open filing 3 |
| Bpifrance Participations SA Other: Member of 10% owner group | Ordinary Shares | 226,133 | I By Innobio FPCI | As of 2025-12-19 Open filing 4 |
| Bpifrance Participations SA Other: Member of 10% owner group | Ordinary Shares | 7,303,369 | I By Bpifrance Participations S.A. | As of 2025-12-18 Open filing 4 |
| Bpifrance SA 10% owner | Ordinary Shares | 10,672,462 | I By Bpifrance Participations S.A. | As of 2025-04-07 Open filing 3 |
| Bpifrance SA Other: Member of 10% owner group | Ordinary Shares | 226,133 | I By Innobio FPCI | As of 2025-12-19 Open filing 4 |
| Bpifrance SA Other: Member of 10% owner group | Ordinary Shares | 7,303,369 | I By Bpifrance Participations S.A. | As of 2025-12-18 Open filing 4 |
| CAISSE DES DEPOTS ET CONSIGNATIONS 10% owner | Ordinary Shares | 10,672,462 | I By Bpifrance Participations S.A. | As of 2025-04-07 Open filing 3 |
| CAISSE DES DEPOTS ET CONSIGNATIONS Other: Member of 10% owner group | Ordinary Shares | 226,133 | I By Innobio FPCI | As of 2025-12-19 Open filing 4 |
| CAISSE DES DEPOTS ET CONSIGNATIONS Other: Member of 10% owner group | Ordinary Shares | 7,303,369 | I By Bpifrance Participations S.A. | As of 2025-12-18 Open filing 4 |
| EPIC Bpifrance Other: Member of 10% owner group | Ordinary Shares | 10,672,462 | I By Bpifrance Participations S.A. | As of 2025-05-20 Open filing 3 |
| EPIC Bpifrance Other: Member of 10% owner group | Ordinary Shares | 226,133 | I By Innobio FPCI | As of 2025-12-19 Open filing 4 |
| EPIC Bpifrance Other: Member of 10% owner group | Ordinary Shares | 7,303,369 | I By Bpifrance Participations S.A. | As of 2025-12-18 Open filing 4 |
| Mohideen Pharis Officer: Chief Medical Officer | Employee Stock Option (right to buy) Derivative security · underlying Ordinary Shares | 253,000 | D | As of 2025-11-21 Open filing 4 |
| Mohideen Pharis Officer: Chief Medical Officer | Ordinary Shares | 144,531 | D | As of 2026-07-29 Open filing 4 |
| Tasse Daniel Director · Officer: CHIEF EXECUTIVE OFFICER | Employee Stock Option (right to buy) Derivative security · underlying Ordinary Shares | 964,000 | D | As of 2025-11-21 Open filing 4 |
| Trapp Kevin Michael Officer: Chief Commercial Officer | Employee Stock Option (right to buy) Derivative security · underlying Ordinary Shares | 316,250 | D | As of 2025-11-21 Open filing 4 |
| Trapp Kevin Michael Officer: Chief Commercial Officer | Ordinary Shares | 55,000 | D | As of 2025-11-21 Open filing 4 |
Joint filers each report the same shares, so rows are not added together.
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.
Showing 1–50 of 66
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 3,657,644 SH | 43,013,893 dollars | Not in the prior quarter’s filings read | Open filing 0001104659-26-128411 Filed 2026-11-16 Dispute this row |
| MPM BIOIMPACT LLC | 3,044,659 SH | 35,805,190 dollars | Lower by 621,625 Prior quarter: 3,666,284 | Open filing 0001193125-26-463462 Filed 2026-11-16 Dispute this row |
| Siren, L.L.C. Partly reported under another manager | 2,356,539 SH | 27,712,899 dollars | Higher by 499,177 Prior quarter: 1,857,362 | Open filing 0002005245-26-000013 Filed 2026-11-12 Dispute this row |
| ADAR1 Capital Management, LLC | 2,010,831 SH | 23,647,373 dollars | Higher by 1,482,536 Prior quarter: 528,295 | Open filing 0001940272-26-000033 Filed 2026-11-16 Dispute this row |
| Vivo Capital, LLC | 1,844,758 SH | 21,694,354 dollars | Unchanged Prior quarter: 1,844,758 | Open filing 0001213900-26-119459 Filed 2026-11-13 Dispute this row |
| Artisan Partners Limited Partnership | 1,584,020 SH | 18,628,075 dollars | Higher by 211,169 Prior quarter: 1,372,851 | Open filing 0001466153-26-000009 Filed 2026-11-13 Dispute this row |
| BAKER BROS. ADVISORS LP | 1,461,425 SH | 17,186,358 dollars | Unchanged Prior quarter: 1,461,425 | Open filing 0001104659-26-128308 Filed 2026-11-16 Dispute this row |
| UBS Group AG Partly reported under another manager | 1,435,282 SH | 16,878,917 dollars | Higher by 121,843 Prior quarter: 1,313,439 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| PERCEPTIVE ADVISORS LLC | 1,136,534 SH | 13,365,640 dollars | Lower by 516,816 Prior quarter: 1,653,350 | Open filing 0001012975-26-001063 Filed 2026-11-16 Dispute this row |
| Patient Square Capital LP | 1,105,606 SH | 13,001,927 dollars | Higher by 196,132 Prior quarter: 909,474 | Open filing 0001819257-26-000007 Filed 2026-11-10 Dispute this row |
| Octagon Capital Advisors LP | 574,200 SH | 6,752,592 dollars | Unchanged Prior quarter: 574,200 | Open filing 0001839435-26-000006 Filed 2026-11-16 Dispute this row |
| MILLENNIUM MANAGEMENT LLC | 552,991 SH | 6,503,174 dollars | Higher by 285,208 Prior quarter: 267,783 | Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row |
| Ikarian Capital, LLC | 453,374 SH | 1,065,356 dollars | Lower by 71,626 Prior quarter: 525,000 | Open filing 0001420506-26-002881 Filed 2026-11-16 Dispute this row |
| FMR LLC Partly reported under another manager | 428,800 SH | 5,042,688 dollars | Not in the prior quarter’s filings read | Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row |
| AMERIPRISE FINANCIAL INC Partly reported under another manager | 415,466 SH | 4,885,881 dollars | Higher by 36,969 Prior quarter: 378,497 | Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row |
| Redmile Group, LLC | 373,417 SH | 4,391,384 dollars | Lower by 37,023 Prior quarter: 410,440 | Open filing 0000905148-26-004923 Filed 2026-11-16 Dispute this row |
| CITADEL ADVISORS LLC Partly reported under another manager | 276,134 SH | 3,247,336 dollars | Higher by 253,352 Prior quarter: 22,782 | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| Ishara Investments LP | 270,000 SH | 3,175,200 dollars | Higher by 85,500 Prior quarter: 184,500 | Open filing 0002111609-26-000005 Filed 2026-11-16 Dispute this row |
| Elmind Capital, LP | 265,000 SH | 3,116,400 dollars | Unchanged Prior quarter: 265,000 | Open filing 0001013594-26-001197 Filed 2026-11-16 Dispute this row |
| GREAT POINT PARTNERS LLC Partly reported under another manager | 250,000 SH | 2,940,000 dollars | Higher by 93,094 Prior quarter: 156,906 | Open filing 0001172661-26-005345 Filed 2026-11-16 Dispute this row |
| JANE STREET GROUP, LLC Partly reported under another manager | 185,410 SH | 2,180,422 dollars | Lower by 38,505 Prior quarter: 223,915 | Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row |
| Duquesne Family Office LLC | 173,028 SH | 2,035 dollars | Lower by 210,335 Prior quarter: 383,363 | Open filing 0001536411-26-000011 Filed 2026-11-16 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 171,622 SH | 2,018,274 dollars | Lower by 783,286 Prior quarter: 954,908 | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| Yiheng Capital Management, L.P. | 170,142 SH | 2,000,870 dollars | Unchanged Prior quarter: 170,142 | Open filing 0001420506-26-002824 Filed 2026-11-16 Dispute this row |
| BOOTHBAY FUND MANAGEMENT, LLC | 141,703 SH | 1,666,427 dollars | Lower by 21,698 Prior quarter: 163,401 | Open filing 0001549230-26-000012 Filed 2026-11-16 Dispute this row |
| Russell Investments Group, Ltd. Partly reported under another manager | 80,917 SH | 951,583 dollars | Lower by 3,279 Prior quarter: 84,196 | Open filing 0001193125-26-451241 Filed 2026-11-06 Dispute this row |
| Polymer Capital Management (HK) LTD | 64,500 SH | 758,520 dollars | Unchanged Prior quarter: 64,500 | Open filing 0001970465-26-000010 Filed 2026-11-13 Dispute this row |
| DEUTSCHE BANK AG\ Partly reported under another manager | 59,240 SH | 696,662 dollars | Unchanged Prior quarter: 59,240 | Open filing 0000948046-26-000083 Filed 2026-11-06 Dispute this row |
| Qube Research Technologies Ltd | 48,158 SH | 566,338 dollars | Higher by 19,353 Prior quarter: 28,805 | Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row |
| TWO SIGMA INVESTMENTS, LP | 44,552 SH | 523,932 dollars | Higher by 32,922 Prior quarter: 11,630 | Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row |
| WELLS FARGO COMPANY/MN Partly reported under another manager | 37,500 SH | 441,000 dollars | Higher by 37,200 Prior quarter: 300 | Open filing 0000072971-26-000342 Filed 2026-11-16 Dispute this row |
| ENVESTNET ASSET MANAGEMENT INC | 30,831 SH | 362,573 dollars | Lower by 82,992 Prior quarter: 113,823 | Open filing 0001214659-26-014231 Filed 2026-11-16 Dispute this row |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager | 30,100 SH | 353,976 dollars | Not in the prior quarter’s filings read | Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row |
| XTX Topco Ltd Partly reported under another manager | 26,517 SH | 311,840 dollars | Lower by 64,685 Prior quarter: 91,202 | Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row |
| HRT FINANCIAL LP | 25,492 SH | 299 dollars | Lower by 125,705 Prior quarter: 151,197 | Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row |
| Cetera Investment Advisers | 22,918 SH | 269,516 dollars | Lower by 12,339 Prior quarter: 35,257 | Open filing 0001666741-26-000005 Filed 2026-11-13 Dispute this row |
| China Universal Asset Management Co., Ltd. | 21,600 SH | 249,480 dollars | Higher by 13,600 Prior quarter: 8,000 | Open filing 0001906594-26-000005 Filed 2026-10-28 Dispute this row |
| Persistent Asset Partners Ltd | 18,902 SH | 222,288 dollars | Higher by 3,272 Prior quarter: 15,630 | Open filing 0002056052-26-000005 Filed 2026-11-13 Dispute this row |
| Engineers Gate Manager LP | 14,200 SH | 166,992 dollars | Lower by 18,239 Prior quarter: 32,439 | Open filing 0001620220-26-000010 Filed 2026-11-16 Dispute this row |
| SEI INVESTMENTS CO Partly reported under another manager | 13,326 SH | 156,719 dollars | Higher by 2,517 Prior quarter: 10,809 | Open filing 0000350894-26-000059 Filed 2026-11-10 Dispute this row |
| Vontobel Holding Ltd. Partly reported under another manager | 12,248 SH | 144,036 dollars | Not in the prior quarter’s filings read | Open filing 0001588340-26-000004 Filed 2026-10-16 Dispute this row |
| CITADEL ADVISORS LLC Option: Call Partly reported under another manager | 10,100 SH | 118,776 dollars | Not in the prior quarter’s filings read | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| RHUMBLINE ADVISERS | 5,366 SH | 63,097 dollars | Lower by 245 Prior quarter: 5,611 | Open filing 0001115418-26-000015 Filed 2026-11-10 Dispute this row |
| BARCLAYS PLC Partly reported under another manager | 4,784 SH | 56,260 dollars | Lower by 2,414 Prior quarter: 7,198 | Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row |
| GAMMA Investing LLC Partly reported under another manager | 2,607 SH | 30,658 dollars | Lower by 225 Prior quarter: 2,832 | Open filing 0002010235-26-000007 Filed 2026-10-08 Dispute this row |
| Allworth Financial LP | 1,683 SH | 19,793 dollars | Unchanged Prior quarter: 1,683 | Open filing 0001140361-26-044466 Filed 2026-11-17 Dispute this row |
| State of Wyoming | 957 SH | 11,254 dollars | Lower by 488 Prior quarter: 1,445 | Open filing 0001821626-26-000009 Filed 2026-10-28 Dispute this row |
| JPMORGAN CHASE CO Partly reported under another manager | 907 SH | 10,476 dollars | Higher by 854 Prior quarter: 53 | Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row |
| Tower Research Capital LLC (TRC) Partly reported under another manager | 837 SH | 9,843 dollars | Not in the prior quarter’s filings read | Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row |
| Continuum Advisory, LLC | 400 SH | 4,704 dollars | Unchanged Prior quarter: 400 | Open filing 0001420506-26-002682 Filed 2026-11-13 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- Logos Global Management LP 915,000 SH
- NEW YORK STATE COMMON RETIREMENT FUND 119,335 SH
- Diversify Advisory Services, LLC 89,692 SH
- DIVERSIFY WEALTH MANAGEMENT, LLC 89,692 SH
- Dorsey Wright Associates 73,115 SH
- LPL Financial LLC 53,751 SH
- AdvisorShares Investments LLC 43,663 SH
- STIFEL FINANCIAL CORP 27,608 SH
- Burns Matteson Capital Management, LLC 21,818 SH
- Atria Investments, Inc 18,902 SH
- PERSONAL CFO SOLUTIONS, LLC 12,940 SH
- Point72 Asset Management, L.P. 12,148 SH
- GEODE CAPITAL MANAGEMENT, LLC 11,574 SH
- Integrated Wealth Concepts LLC 10,369 SH
- Optiver Holding B.V. 6,455 SH
- BERTHEL, FISHER COMPANY FINANCIAL SERVICES, INC. 6,349 SH
- Truvestments Capital LLC 3,892 SH
- Rockefeller Capital Management L.P. 1,246 SH
- HM PAYSON CO 420 SH
- Ascentis Wealth Management, LLC 259 SH
- NISA INVESTMENT ADVISORS, LLC 200 SH
- Farther Finance Advisors, LLC 164 SH
- Stone House Investment Management, LLC 9 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- Reports for quarters ending before 2013-06-30 were filed as plain text; they are read only when their rows add up to the totals the filer states.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Institutional ownership reported on Form 13F
13F filers report holding between 5.97% and 7.91% of shares outstanding.
Quarter ending 2026-09-30, against 314,388,807 shares on the cover dated 2026-10-26.
- The lower figure counts positions a manager reports as its own with sole discretion. The upper figure counts every plain-share position and can count a share twice.
- Neither includes holders that do not file Form 13F, or managers below the filing threshold.
| Quarter | Managers holding | Shares, at least | Shares, at most | Filings read |
|---|---|---|---|---|
| 2026-09-30 | 64 | 18,779,509 | 24,878,461 | 8,935 |
| 2026-06-30 | 80 | 15,605,484 | 21,540,591 | 9,178 |
| 2026-03-31 | 73 | 17,754,504 | 21,190,343 | 9,173 |
| 2025-12-31 | 52 | 13,260,459 | 16,176,096 | 9,222 |
| 2025-09-30 | 33 | 6,069,050 | 6,519,308 | 8,469 |
| 2025-06-30 | 30 | 6,642,491 | 7,232,641 | 8,516 |
| 2025-03-31 | 18 | 2,121,925 | 2,467,962 | 8,518 |
| 2024-12-31 | 19 | 2,152,980 | 2,737,085 | 8,580 |
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read from their tags. Earlier schedules are free text: they are read only when every cover page states a share count and a percent, and the rest are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| MPM BioImpact LLC Ordinary Shares, nominal value 0.10 euro per share | 4.8 | 15,223,295.00 | 09/30/2026 Filed 2026-11-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0001687078-26-000024 Dispute this row |
| Invus Public Equities, L.P. Ordinary Shares, nominal value Euro 0.10 per share | 7.3 | 23,095,116.00 | 09/30/2026 Filed 2026-11-12 | SCHEDULE 13G/AAmendment 3 | Open filing 0002005369-26-000058 Dispute this row |
| Invus Public Equities Advisors, LLC Ordinary Shares, nominal value Euro 0.10 per share | 7.3 | 23,095,116.00 | 09/30/2026 Filed 2026-11-12 | SCHEDULE 13G/AAmendment 3 | Open filing 0002005369-26-000058 Dispute this row |
| Invus Global Management, LLC Ordinary Shares, nominal value Euro 0.10 per share | 7.3 | 23,095,116.00 | 09/30/2026 Filed 2026-11-12 | SCHEDULE 13G/AAmendment 3 | Open filing 0002005369-26-000058 Dispute this row |
| Siren, L.L.C. Ordinary Shares, nominal value Euro 0.10 per share | 7.3 | 23,095,116.00 | 09/30/2026 Filed 2026-11-12 | SCHEDULE 13G/AAmendment 3 | Open filing 0002005369-26-000058 Dispute this row |
| Avicenna Life Sci Master Fund LP Ordinary Shares, nominal value Euro 0.10 per share | 0.5 | 1,621,060.00 | 09/30/2026 Filed 2026-11-12 | SCHEDULE 13G/AAmendment 3 | Open filing 0002005369-26-000058 Dispute this row |
| Avicenna Life Sci Master GP LLC Ordinary Shares, nominal value Euro 0.10 per share | 0.5 | 1,621,060.00 | 09/30/2026 Filed 2026-11-12 | SCHEDULE 13G/AAmendment 3 | Open filing 0002005369-26-000058 Dispute this row |
| Ulys, L.L.C. Ordinary Shares, nominal value Euro 0.10 per share | 0.5 | 1,621,060.00 | 09/30/2026 Filed 2026-11-12 | SCHEDULE 13G/AAmendment 3 | Open filing 0002005369-26-000058 Dispute this row |
| Raymond Debbane Ordinary Shares, nominal value Euro 0.10 per share | 7.9 | 24,716,176.00 | 09/30/2026 Filed 2026-11-12 | SCHEDULE 13G/AAmendment 3 | Open filing 0002005369-26-000058 Dispute this row |
| RA Capital Management, L.P. Ordinary shares, nominal value EUR 0.10 per share | 5.8 | 18,288,220.00 | 07/30/2026 Filed 2026-08-06 | SCHEDULE 13G | Open filing 0001346824-26-000213 Dispute this row |
| Peter Kolchinsky Ordinary shares, nominal value EUR 0.10 per share | 5.8 | 18,288,220.00 | 07/30/2026 Filed 2026-08-06 | SCHEDULE 13G | Open filing 0001346824-26-000213 Dispute this row |
| Rajeev Shah Ordinary shares, nominal value EUR 0.10 per share | 5.8 | 18,288,220.00 | 07/30/2026 Filed 2026-08-06 | SCHEDULE 13G | Open filing 0001346824-26-000213 Dispute this row |
| RA Capital Healthcare Fund, L.P. Ordinary shares, nominal value EUR 0.10 per share | 5.8 | 18,288,220.00 | 07/30/2026 Filed 2026-08-06 | SCHEDULE 13G | Open filing 0001346824-26-000213 Dispute this row |
| MPM BioImpact LLC Ordinary Shares, nominal value 0.10 euro per share | 6.2 | 18,331,420.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001687078-26-000019 Dispute this row |
| MPM BioImpact LLC Ordinary Shares, nominal value 0.10 euro per share | 8.8 | 26,066,806.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0001687078-26-000012 Dispute this row |
| Artisan Partners Asset Management Inc. American Depositary Shares | 3.7 | 2,219,386 | 03/31/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-220564 Dispute this row |
| Artisan Partners Holdings LP American Depositary Shares | 3.7 | 2,219,386 | 03/31/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-220564 Dispute this row |
| Artisan Investments GP LLC American Depositary Shares | 3.7 | 2,219,386 | 03/31/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-220564 Dispute this row |
| Artisan Partners Limited Partnership American Depositary Shares | 3.7 | 2,219,386 | 03/31/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-220564 Dispute this row |
| Adage Capital Management, L.P. Ordinary Shares, nominal value 0.10 euro per share | 7.31 | 22,272,884.00 | 03/31/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-002909 Dispute this row |
| Robert Atchinson Ordinary Shares, nominal value 0.10 euro per share | 7.31 | 22,272,884.00 | 03/31/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-002909 Dispute this row |
| Phillip Gross Ordinary Shares, nominal value 0.10 euro per share | 7.31 | 22,272,884.00 | 03/31/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-002909 Dispute this row |
| Vivo Opportunity Fund Holdings, L.P. Ordinary shares, nominal value 0.10 euro per share, represented by American Depository Shares | 4.0 | 11,820,005.00 | 03/31/2026 Filed 2026-05-12 | SCHEDULE 13G/AAmendment 2 | Open filing 0001213900-26-055373 Dispute this row |
| Vivo Opportunity, LLC Ordinary shares, nominal value 0.10 euro per share, represented by American Depository Shares | 4.0 | 11,820,005.00 | 03/31/2026 Filed 2026-05-12 | SCHEDULE 13G/AAmendment 2 | Open filing 0001213900-26-055373 Dispute this row |
| Vivo Opportunity Cayman Fund, L.P. Ordinary shares, nominal value 0.10 euro per share, represented by American Depository Shares | 0.5 | 1,517,840.00 | 03/31/2026 Filed 2026-05-12 | SCHEDULE 13G/AAmendment 2 | Open filing 0001213900-26-055373 Dispute this row |
| Vivo Opportunity Cayman, LLC Ordinary shares, nominal value 0.10 euro per share, represented by American Depository Shares | 0.5 | 1,517,840.00 | 03/31/2026 Filed 2026-05-12 | SCHEDULE 13G/AAmendment 2 | Open filing 0001213900-26-055373 Dispute this row |
| Invus Public Equities, L.P. Ordinary Shares, nominal value Euro 0.10 per share | 6.1 | 17,997,870.00 | 03/31/2026 Filed 2026-05-05 | SCHEDULE 13G/AAmendment 2 | Open filing 0002005369-26-000033 Dispute this row |
| Invus Public Equities Advisors, LLC Ordinary Shares, nominal value Euro 0.10 per share | 6.1 | 17,997,870.00 | 03/31/2026 Filed 2026-05-05 | SCHEDULE 13G/AAmendment 2 | Open filing 0002005369-26-000033 Dispute this row |
| Invus Global Management, LLC Ordinary Shares, nominal value Euro 0.10 per share | 6.1 | 17,997,870.00 | 03/31/2026 Filed 2026-05-05 | SCHEDULE 13G/AAmendment 2 | Open filing 0002005369-26-000033 Dispute this row |
| Siren, L.L.C. Ordinary Shares, nominal value Euro 0.10 per share | 6.1 | 17,997,870.00 | 03/31/2026 Filed 2026-05-05 | SCHEDULE 13G/AAmendment 2 | Open filing 0002005369-26-000033 Dispute this row |
| Avicenna Life Sci Master Fund LP Ordinary Shares, nominal value Euro 0.10 per share | 0.4 | 1,312,135.00 | 03/31/2026 Filed 2026-05-05 | SCHEDULE 13G/AAmendment 2 | Open filing 0002005369-26-000033 Dispute this row |
| Avicenna Life Sci Master GP LLC Ordinary Shares, nominal value Euro 0.10 per share | 0.4 | 1,312,135.00 | 03/31/2026 Filed 2026-05-05 | SCHEDULE 13G/AAmendment 2 | Open filing 0002005369-26-000033 Dispute this row |
| Ulys, L.L.C. Ordinary Shares, nominal value Euro 0.10 per share | 0.4 | 1,312,135.00 | 03/31/2026 Filed 2026-05-05 | SCHEDULE 13G/AAmendment 2 | Open filing 0002005369-26-000033 Dispute this row |
| Raymond Debbane Ordinary Shares, nominal value Euro 0.10 per share | 6.5 | 19,310,005.00 | 03/31/2026 Filed 2026-05-05 | SCHEDULE 13G/AAmendment 2 | Open filing 0002005369-26-000033 Dispute this row |
| Vivo Opportunity Fund Holdings, L.P. Ordinary shares, nominal value 0.10 euro per share, presented by American Depository Shares | 5.7 | 15,685,950.00 | 01/12/2026 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001213900-26-016649 Dispute this row |
| Vivo Opportunity, LLC Ordinary shares, nominal value 0.10 euro per share, presented by American Depository Shares | 5.7 | 15,685,950.00 | 01/12/2026 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001213900-26-016649 Dispute this row |
| Vivo Opportunity Cayman Fund, L.P. Ordinary shares, nominal value 0.10 euro per share, presented by American Depository Shares | 0.7 | 2,014,280.00 | 01/12/2026 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001213900-26-016649 Dispute this row |
| Vivo Opportunity Cayman, LLC Ordinary shares, nominal value 0.10 euro per share, presented by American Depository Shares | 0.7 | 2,014,280.00 | 01/12/2026 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001213900-26-016649 Dispute this row |
| Baker Bros. Advisors LP Ordinary shares, nominal value 0.10 euro per share | 9.99 | 25,586,190.00 | 01/12/2026 Filed 2026-01-14 | SCHEDULE 13D/AAmendment 9 | Open filing 0001104659-26-003806 Dispute this row |
| Baker Bros. Advisors (GP) LLC Ordinary shares, nominal value 0.10 euro per share | 9.99 | 25,586,190.00 | 01/12/2026 Filed 2026-01-14 | SCHEDULE 13D/AAmendment 9 | Open filing 0001104659-26-003806 Dispute this row |
| Julian C. Baker Ordinary shares, nominal value 0.10 euro per share | 9.99 | 25,586,190.00 | 01/12/2026 Filed 2026-01-14 | SCHEDULE 13D/AAmendment 9 | Open filing 0001104659-26-003806 Dispute this row |
| Felix J. Baker Ordinary shares, nominal value 0.10 euro per share | 9.99 | 25,586,190.00 | 01/12/2026 Filed 2026-01-14 | SCHEDULE 13D/AAmendment 9 | Open filing 0001104659-26-003806 Dispute this row |
| Bpifrance Participations S.A. Ordinary Shares, nominal value EUR0.10 per share | 4.6 | 10,672,462.00 | 01/05/2026 Filed 2026-01-07 | SCHEDULE 13D/AAmendment 10 | Open filing 0001104659-26-001744 Dispute this row |
| Innobio FPCI Ordinary Shares, nominal value EUR0.10 per share | 0.1 | 226,133.00 | 01/05/2026 Filed 2026-01-07 | SCHEDULE 13D/AAmendment 10 | Open filing 0001104659-26-001744 Dispute this row |
| Bpifrance Investissement SAS Ordinary Shares, nominal value EUR0.10 per share | 0.1 | 226,133.00 | 01/05/2026 Filed 2026-01-07 | SCHEDULE 13D/AAmendment 10 | Open filing 0001104659-26-001744 Dispute this row |
| Caisse des Depots Ordinary Shares, nominal value EUR0.10 per share | 4.7 | 10,898,595.00 | 01/05/2026 Filed 2026-01-07 | SCHEDULE 13D/AAmendment 10 | Open filing 0001104659-26-001744 Dispute this row |
| EPIC Bpifrance Ordinary Shares, nominal value EUR0.10 per share | 4.7 | 10,898,595.00 | 01/05/2026 Filed 2026-01-07 | SCHEDULE 13D/AAmendment 10 | Open filing 0001104659-26-001744 Dispute this row |
| Bpifrance S.A. Ordinary Shares, nominal value EUR0.10 per share | 4.7 | 10,898,595.00 | 01/05/2026 Filed 2026-01-07 | SCHEDULE 13D/AAmendment 10 | Open filing 0001104659-26-001744 Dispute this row |
| Citadel Advisors LLC Ordinary shares, nominal value EUR0.10 per share (the "Shares") | 3.1 | 7,413,959.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-016493 Dispute this row |
| Citadel Advisors Holdings LP Ordinary shares, nominal value EUR0.10 per share (the "Shares") | 3.1 | 7,413,959.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-016493 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
3,104,499 filings read, dated 1980-01-02 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 258,595 |
| 2016 | 246,472 |
| 2017 | 244,814 |
| 2018 | 245,575 |
| 2019 | 238,619 |
| 2020 | 249,093 |
| 2021 | 274,850 |
| 2022 | 257,922 |
| 2023 | 253,676 |
| 2024 | 261,106 |
| 2025 | 235,525 |
| 2026 | 263,830 |
Filings made before the SEC required XML are listed, not extracted.